Downey Gregory's Form 4 filing
Lexaria Bioscience Corp. (LEXX) · filed Oct 18, 2022
- Accession no.
- 0001855763-22-000018
- Filed
- Oct 18, 2022
- Trade date
- Oct 14, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001855763-22-000020 (Oct 18, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Downey GregoryCIK 0001855801 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2022 | common shares | AGrant or awardAcquired | +121 | $2.09 | +$252.89 | 1,954 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.